Antibe Therapeutics is a diversified biotech with two best-in-class divisions in pain/inflammation and regenerative medicine.
2025/1/13 17:33:04
(ATE:TSX.V - ATBPF:OTCQX)
Analyst coverage
Streetwise Reports Articles